Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Unique occurrence of trichilemmal carcinoma in the scrotal skin of a giant panda: a pathological analysis.

Created on 27 Jun 2026

Authors

Chengyao Li, Zongliang Xiong, Shanshan Ling, Yan Zhu, Linhua Deng, Mengfang Yang, Chengdong Wang, Qian Wang, Danyu Chen, Mao Huang, Kao Wang, Desheng Li, Zhengli Chen, Caiwu Li

Published in

BMC veterinary research. Jun 26, 2026. Epub Jun 26, 2026.

Abstract

Trichilemmal carcinoma (TC) is a rare cutaneous appendage malignancy with scarce human cases and very few animal cases have been documented in the available literature, especially in giant pandas.
A 23-year-old male captive giant panda had 4-week scrotal hyperplasia and ulceration, with a 4.5 cm×4 cm irregular lesion and neutrophils were elevated. Pathology revealed dermal lobular/cord-like invasive atypical clear cells, squamous nests and outer root sheath cysts. PAS staining was positive. Immunohistochemistry showed Her-2 (+), CK5/6 (++), p63 (++), Ki-67 (+), CD34 (+), and p53 (+), excluding squamous cell carcinoma and trichofolliculoma. Local resection (0.8 cm margin) was done under general anesthesia. Postoperative anti-infection led to 2-week wound healing; 3-month follow-up showed no recurrence with normal behavior.
This first reported giant panda TC with human-like immunophenotype provides evidence for managing rare animal cutaneous appendage tumors.

PMID:
42363183
Bibliographic data and abstract were imported from PubMed on 27 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement